Cargando…

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study

Infection of SARS-CoV-2 among health workers (HWs) in contact with cancer patients has been a major issue since the beginning of the pandemic. We aimed to assess the serological immune status of SARS-CoV-2 infection among these HWs. A prospective cohort study was initiated in the comprehensive cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richez, Brice, Cantarel, Coralie, Durrieu, Françoise, Soubeyran, Isabelle, Blanchi, Julie, Pernot, Simon, Chakiba Brugère, Camille, Roubaud, Guilhem, Cousin, Sophie, Etienne, Gabriel, Floquet, Anne, Babre, Florence, Rivalan, Julie, Lalet, Caroline, Narbonne, Marine, Belaroussi, Yaniss, Bellera, Carine, Mathoulin-Pélissier, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252859/ https://www.ncbi.nlm.nih.gov/pubmed/37297553 http://dx.doi.org/10.3390/ijerph20115949

Ejemplares similares

Suivi de la réponse sérologique au virus SARS-CoV-2 chez des professionnels de santé d'un centre de lutte contre le cancer dans un contexte de pandémie de COVID19 (PRO-SERO-COV)
por: Cantarel, C., et al.
Publicado: (2022)

Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
por: Belaroussi, Yaniss, et al.
Publicado: (2023)

Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial
por: Soubeyran, Pierre, et al.
Publicado: (2016)

One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score
por: Bourdel-Marchasson, Isabelle, et al.
Publicado: (2016)

Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
por: Belaroussi, Yaniss, et al.
Publicado: (2020)

Perspectives on cancer care in older patients in France
por: Hauchecorne, Mathilde, et al.
Publicado: (2020)

P043 - Délais de prise en charge des sarcomes au sein des centres labellisés NETSARC+ pendant l’épidémie de COVID-19 et analyse des déterminants: étude COV-PEC-SARC
por: Cantarel, C., et al.
Publicado: (2023)

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison
por: Penel, Nicolas, et al.
Publicado: (2023)

Effet de la 1,3,7-Trimethylxanthine en cas de maladie COVID-19. Étude bicentrique comparative : réduction de la durée d’hospitalisation
por: Bleibtreu, A., et al.
Publicado: (2020)

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
por: Bellera, Carine A, et al.
Publicado: (2010)

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer
por: Cousin, Sophie, et al.
Publicado: (2022)

Adenosquamous Carcinoma of the Pancreas
por: Del Arco, Hélène, et al.
Publicado: (2019)

Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF)
por: Greillier, Laurent, et al.
Publicado: (2022)

SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study
por: Puchades, Alice, et al.
Publicado: (2022)

Sero‐prevalence of SARS‐CoV‐2 in certain cities of Kazakhstan
por: Smagul, Manar, et al.
Publicado: (2022)

Breast cancer care compared with clinical Guidelines: an observational study in France
por: Lebeau, Marie, et al.
Publicado: (2011)

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
por: Arora, Rahul K, et al.
Publicado: (2021)

Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership
Publicado: (2021)

Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination
por: Muhsen, Khitam, et al.
Publicado: (2021)

Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
por: Toulmonde, Maud, et al.
Publicado: (2022)

FOLFIRI(®) and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms
por: Bécouarn, Yves, et al.
Publicado: (2014)

Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up
por: de Mascarel, Isabelle, et al.
Publicado: (2007)

Factors influencing general practitioners in the referral of elderly cancer patients
por: Delva, Fleur, et al.
Publicado: (2011)

Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2
por: Routledge, Isobel, et al.
Publicado: (2021)

Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2
por: Routledge, Isobel, et al.
Publicado: (2022)

Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam
por: Hasan, Tasnim, et al.
Publicado: (2021)

Population-based sero-epidemiological investigation of SARS-CoV-2 infection in Somalia
por: Hossain, Md Shajib, et al.
Publicado: (2023)

Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial
por: Palussière, J., et al.
Publicado: (2018)

Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial
por: Evrard, Serge, et al.
Publicado: (2019)

Futile lobectomies following video-thoracoscopic exploration for indeterminate pulmonary nodules: a retrospective study
por: Drevet, Gabrielle, et al.
Publicado: (2022)

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study
por: Soubeyran, Pierre, et al.
Publicado: (2014)

PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)
por: Grellety, Thomas, et al.
Publicado: (2016)

Brief Report on Teleconsultation in Lung Cancer: Toward a Semiotic Paradigm Shift?
por: Thomas, Quentin Dominique, et al.
Publicado: (2022)

Laparoscopic fundoplication for para-oesophageal hernia repair improves respiratory function in patients with dyspnoea: a prospective cohort study
por: Bouriez, Damien, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France
por: Gégout Petit, Anne, et al.
Publicado: (2021)

Asymptomatic SARS-COV-2 carriage and sero-positivity in high risk contacts of COVID-19 cases’
por: Das, Ayan Kumar, et al.
Publicado: (2022)

Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts
por: Oubaya, Nadia, et al.
Publicado: (2021)

The Ross Operation in Young Patients: A 15-Year Experience Focused on Right Ventricle to Pulmonary Artery Conduit Outcomes
por: Dib, Nabil, et al.
Publicado: (2022)

Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies
por: Tudrej, Benoit, et al.
Publicado: (2020)

The Sero-Diagnosis of Syphilis
por: Sutherland, W. D.
Publicado: (1913)

Cannot write session to /tmp/vufind_sessions/sess_tm82saqfi7f9srrhr6758fghl5